GNH USA

Europe — EMA

Kynmobi (Anhydrous Apomorphine Hydrochloride)

GNH USA supplies Kynmobi (Apomorphine), a dopamine agonist for OFF episodes in Parkinson's disease. Request a quote for global supply.

Anhydrous Apomorphine Hydrochloride

Request sourcing

1
Pack/s

What is Anhydrous Apomorphine Hydrochloride?

Apomorphine hydrochloride, the active ingredient in Kynmobi, is a dopamine agonist presented as a 10 mg sublingual film for sublingual use. It treats OFF episodes in Parkinson's disease in adult patients.

GNH USA supplies Kynmobi as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Anhydrous Apomorphine Hydrochloride used for?

Apomorphine hydrochloride is used to manage motor fluctuations in Parkinson's disease by stimulating dopaminergic pathways.

- OFF episodes in Parkinson's disease: rapid reversal of motor symptoms during OFF periods. - Motor fluctuations in Parkinson's disease: reduces frequency and severity of OFF episodes. - Parkinson's disease patients with delayed levodopa response: provides supplemental dopaminergic stimulation.

What are the side effects of Anhydrous Apomorphine Hydrochloride?

Apomorphine may cause a range of adverse reactions, some of which are common and others that are serious or rare.

Common Side Effects: - Nausea - Vomiting - Dizziness - Orthostatic hypotension - Headache - Somnolence

Serious or Rare Side Effects: - Severe hypotension or syncope - Hallucinations or psychosis - Impulse control disorders - Severe nausea or vomiting requiring medical attention - Cardiac arrhythmias - Pulmonary edema

What precautions apply to Anhydrous Apomorphine Hydrochloride?

When using Kynmobi, several safety considerations should be observed.

- Dose titration: start low and increase gradually under medical supervision. - Cardiovascular monitoring: watch for hypotension and syncope. - Nausea prophylaxis: consider antiemetic before first dose. - Contraindication in severe cardiac disease: avoid use in patients with unstable heart conditions. - Pregnancy and breastfeeding: use only if benefit outweighs potential risk (category unknown). - Store below 25°C: keep in the original pack, protect from moisture.

What does Anhydrous Apomorphine Hydrochloride interact with?

Apomorphine can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Antihypertensive agents: additive hypotensive effect. - Other dopamine agonists: increased risk of cumulative side effects.

Moderate Interactions (Monitor Closely): - Antiemetics such as metoclopramide: may antagonize apomorphine's effect. - Antipsychotics (e.g., haloperidol): may reduce therapeutic efficacy. - Alcohol: may enhance central nervous system depression.

Frequently asked questions

What is Kynmobi used for?+
Kynmobi is indicated for the rapid reversal of OFF episodes in Parkinson's disease. It provides supplemental dopaminergic stimulation to improve motor function when patients experience sudden worsening of symptoms despite ongoing therapy.
How does apomorphine work in Kynmobi?+
Apomorphine, the active ingredient in Kynmobi, is a non‑selective dopamine D1/D2 receptor agonist. By directly activating these receptors in the brain, it bypasses the need for endogenous dopamine and quickly restores dopaminergic signaling, alleviating motor impairment.
What is the usual dose of Kynmobi?+
The prescribed dose of Kynmobi is individualized by the treating physician. The prescriber determines the appropriate strength, frequency, and titration schedule based on the patient’s clinical response and tolerance.
Is Kynmobi safe during pregnancy or breastfeeding?+
The safety of Kynmobi in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Kynmobi from GNH USA?+
To order Kynmobi, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Kynmobi compare with other Parkinson's treatments?+
Kynmobi offers a rapid, sublingual route of administration, which can be faster than oral levodopa or transdermal therapies. It is particularly useful for patients who need immediate relief of OFF episodes, whereas other dopamine agonists may have slower onset or require different dosing schedules.
What are the storage requirements for Kynmobi?+
Kynmobi should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the film’s stability and ensures consistent drug delivery.
How is Kynmobi administered?+
Kynmobi is a sublingual film placed under the tongue. The film dissolves rapidly, allowing the drug to be absorbed directly into the bloodstream through the oral mucosa, providing quick onset of action without the need for swallowing.
What are the most serious risks associated with Kynmobi?+
Serious risks include severe hypotension, syncope, hallucinations or psychosis, impulse control disorders, and cardiac arrhythmias. Patients should be monitored closely for these events, especially during dose titration or when combined with other cardiovascular or psychiatric medications.
Who should not use Kynmobi?+
Kynmobi is contraindicated in patients with severe cardiac disease, uncontrolled hypertension, known hypersensitivity to apomorphine, or those taking monoamine oxidase inhibitors. It should also be used with caution in individuals with a history of psychosis or impulse control disorders.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Anhydrous Apomorphine Hydrochloride
Route
Sublingual Use
Manufacturer
Bial - Portela & Cª , Sa
Origin
EU

Related products

Apo-Go

Apo-Go

Anhydrous Apomorphine Hydrochloride

Stada Arzneimittel Ag
EU
Apo-Go

Apo-Go

Anhydrous Apomorphine Hydrochloride

Stada Arzneimittel Ag
EU
Apo-Go Ampoules

Apo-Go Ampoules

Anhydrous Apomorphine Hydrochloride

Stada Arzneimittel Ag
EU
Apomorphine Hcl Sterop

Apomorphine Hcl Sterop

Anhydrous Apomorphine Hydrochloride

Laboratoires Sterop
EU